Lineage Cell Therapeutics
LCTX
#8221
Rank
S$0.21 B
Marketcap
$1.12
Share price
1.22%
Change (1 day)
-36.01%
Change (1 year)

Lineage Cell Therapeutics (LCTX) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : S$46.87 M

According to Lineage Cell Therapeutics 's latest financial reports the company's total liabilities are S$46.87 M. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Lineage Cell Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31S$51.5 M-25.73%
2022-12-31S$69.34 M-38.68%
2021-12-31S$0.11 B566.66%
2020-12-31S$16.96 M-11.59%
2019-12-31S$19.18 M49.18%
2018-12-31S$12.86 M7.1%
2017-12-31S$12 M-31.23%
2016-12-31S$17.46 M-32.23%
2015-12-31S$25.76 M60.1%
2014-12-31S$16.09 M-17.89%
2013-12-31S$19.59 M193.81%
2012-12-31S$6.66 M17.82%
2011-12-31S$5.66 M14.25%
2010-12-31S$4.95 M47.93%
2009-12-31S$3.34 M-56.48%
2008-12-31S$7.69 M66.04%
2007-12-31S$4.63 M20.17%
2006-12-31S$3.85 M7.49%
2005-12-31S$3.58 M86.92%
2004-12-31S$1.91 M-67.73%
2003-12-31S$5.95 M28.57%
2002-12-31S$4.62 M22.52%
2001-12-31S$3.77 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
S$34.58 M-26.22%๐Ÿ‡บ๐Ÿ‡ธ USA